Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy

BACKGROUND: Siponimod is an effective treatment for patients with secondary progressive multiple sclerosis (SPMS), with active disease evidenced by relapses or imaging features characteristic of multiple sclerosis inflammatory activity, however there is a need to evaluate its economic value and sust...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortesi, Paolo Angelo, Antonazzo, Ippazio Cosimo, Gasperini, Claudio, Nica, Mihaela, Ritrovato, Daniela, Mantovani, Lorenzo Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903273/
https://www.ncbi.nlm.nih.gov/pubmed/35259168
http://dx.doi.org/10.1371/journal.pone.0264123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903273/
https://www.ncbi.nlm.nih.gov/pubmed/35259168
http://dx.doi.org/10.1371/journal.pone.0264123

Ejemplares similares